Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species MG Perrelli, P Pagliaro, C Penna World journal of cardiology 3 (6), 186, 2011 | 1202* | 2011 |
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis E Villa, C Cammā, M Marietta, M Luongo, R Critelli, S Colopi, C Tata, ... Gastroenterology 143 (5), 1253-1260. e4, 2012 | 549 | 2012 |
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C S Petta, C Cammā, C Scazzone, C Tripodo, V Di Marco, A Bono, D Cabibi, ... Hepatology 51 (4), 1158-1167, 2010 | 515 | 2010 |
EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version) CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ... Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017 | 464 | 2017 |
Non-alcoholic fatty liver disease pathogenesis: the present and the future S Petta, C Muratore, A Craxi Digestive and Liver Disease 41 (9), 615-625, 2009 | 391 | 2009 |
Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030 C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ... Journal of hepatology 69 (4), 896-904, 2018 | 352 | 2018 |
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ... Hepatology 61 (2), 506-514, 2015 | 345 | 2015 |
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ... Gastroenterology 150 (5), 1219-1230. e6, 2016 | 302 | 2016 |
Statin use and non-alcoholic steatohepatitis in at risk individuals P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ... Journal of hepatology 63 (3), 705-712, 2015 | 258 | 2015 |
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C L Rizzo, V Calvaruso, B Cacopardo, N Alessi, M Attanasio, S Petta, ... American Journal of Gastroenterology 106 (12), 2112-2120, 2011 | 239 | 2011 |
Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis S McPherson, T Hardy, JF Dufour, S Petta, M Romero-Gomez, M Allison, ... The American journal of gastroenterology 112 (5), 740, 2017 | 197 | 2017 |
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 194 | 2019 |
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection S Petta, C Camma, V Di Marco, N Alessi, D Cabibi, R Caldarella, A Licata, ... American Journal of Gastroenterology 103 (5), 1136-1144, 2008 | 188 | 2008 |
Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice G Marchesini, S Petta, R Dalle Grave Hepatology 63 (6), 2032-2043, 2016 | 178 | 2016 |
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ... Digestive and Liver Disease 49 (5), 471-483, 2017 | 177 | 2017 |
Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies S Petta, M Maida, FS Macaluso, M Barbara, A Licata, A Craxė, C Cammā Gastroenterology 150 (1), 145-155. e4, 2016 | 176 | 2016 |
Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, F Tinč, ... Gastroenterology 155 (2), 411-421. e4, 2018 | 151 | 2018 |
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease S Petta, M Maida, FS Macaluso, V Di Marco, C Camma, D Cabibi, A Craxė Hepatology 62 (4), 1101-1110, 2015 | 150 | 2015 |
Cost‐effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C C Camma, S Petta, M Enea, R Bruno, F Bronte, V Capursi, A Cicchetti, ... Hepatology 56 (3), 850-860, 2012 | 144 | 2012 |
Hyperuricemia is associated with histological liver damage in patients with non‐alcoholic fatty liver disease S Petta, C Camma, D Cabibi, V Di Marco, A Craxė Alimentary pharmacology & therapeutics 34 (7), 757-766, 2011 | 143 | 2011 |